Estrogen inhibits vaginal tropoelastin and TGF-β1 production

Nahida Chakhtoura, Yanping Zhang, Keith A Candiotti, Carlos Medina, Peter Takacs

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Introduction and hypothesis: The aim of this study was to quantify the effects of estrogen on vaginal smooth muscle cell (SMC) tropoelastin and transforming growth factor (TGF)-β1 production. Methods: Primary SMC were incubated with estradiol, and cell proliferation was assessed by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay at 48 h. Supernatants were collected and tropoelastin and TGF-β1 levels measured. Results: SMC proliferation was significantly increased by estradiol [relative cell number, mean ± standard error (SE), estradiol 0.1 μM 116 ± 19 % of control (P = NS), 1 μM 127 ± 13 % of control (P < 0.05), 10 μM 153 ± 26 % of control, (P < 0.05)]. Tropoelastin production was significantly decreased by estrogen [mean ± SE, estradiol 0.1 μM 78 ± 2 % of control (P < 0.05), 1 μM 76 ± 4 % of control (P < 0.05), 10 μM 67 ± 3 % of control, (P < 0.05)]. In addition, TGF-β1 production was significantly decreased [mean ± SE, estradiol 0.1 μM 96 ± 4 % of control (P = NS), 1 μM 84 ± 6 % of control (P < 0.05), 10 μM 70 ± 6 % of control, (P < 0.05)]. Conclusion: Estrogen increases vaginal SMC proliferation and inhibits tropoelastin and TGF-β1 production.

Original languageEnglish
Pages (from-to)1791-1795
Number of pages5
JournalInternational Urogynecology Journal and Pelvic Floor Dysfunction
Volume23
Issue number12
DOIs
StatePublished - Dec 1 2012

Fingerprint

Tropoelastin
Transforming Growth Factors
Estradiol
Estrogens
Smooth Muscle Myocytes
Cell Proliferation
Cell Count

Keywords

  • Elastin
  • Estrogen
  • Transforming growth factor β1
  • Vagina

ASJC Scopus subject areas

  • Urology
  • Obstetrics and Gynecology

Cite this

Estrogen inhibits vaginal tropoelastin and TGF-β1 production. / Chakhtoura, Nahida; Zhang, Yanping; Candiotti, Keith A; Medina, Carlos; Takacs, Peter.

In: International Urogynecology Journal and Pelvic Floor Dysfunction, Vol. 23, No. 12, 01.12.2012, p. 1791-1795.

Research output: Contribution to journalArticle

@article{dc90edcb59a14d619bbf1f94cb3bdd76,
title = "Estrogen inhibits vaginal tropoelastin and TGF-β1 production",
abstract = "Introduction and hypothesis: The aim of this study was to quantify the effects of estrogen on vaginal smooth muscle cell (SMC) tropoelastin and transforming growth factor (TGF)-β1 production. Methods: Primary SMC were incubated with estradiol, and cell proliferation was assessed by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay at 48 h. Supernatants were collected and tropoelastin and TGF-β1 levels measured. Results: SMC proliferation was significantly increased by estradiol [relative cell number, mean ± standard error (SE), estradiol 0.1 μM 116 ± 19 {\%} of control (P = NS), 1 μM 127 ± 13 {\%} of control (P < 0.05), 10 μM 153 ± 26 {\%} of control, (P < 0.05)]. Tropoelastin production was significantly decreased by estrogen [mean ± SE, estradiol 0.1 μM 78 ± 2 {\%} of control (P < 0.05), 1 μM 76 ± 4 {\%} of control (P < 0.05), 10 μM 67 ± 3 {\%} of control, (P < 0.05)]. In addition, TGF-β1 production was significantly decreased [mean ± SE, estradiol 0.1 μM 96 ± 4 {\%} of control (P = NS), 1 μM 84 ± 6 {\%} of control (P < 0.05), 10 μM 70 ± 6 {\%} of control, (P < 0.05)]. Conclusion: Estrogen increases vaginal SMC proliferation and inhibits tropoelastin and TGF-β1 production.",
keywords = "Elastin, Estrogen, Transforming growth factor β1, Vagina",
author = "Nahida Chakhtoura and Yanping Zhang and Candiotti, {Keith A} and Carlos Medina and Peter Takacs",
year = "2012",
month = "12",
day = "1",
doi = "10.1007/s00192-012-1828-6",
language = "English",
volume = "23",
pages = "1791--1795",
journal = "International Urogynecology Journal and Pelvic Floor Dysfunction",
issn = "0937-3462",
publisher = "Springer London",
number = "12",

}

TY - JOUR

T1 - Estrogen inhibits vaginal tropoelastin and TGF-β1 production

AU - Chakhtoura, Nahida

AU - Zhang, Yanping

AU - Candiotti, Keith A

AU - Medina, Carlos

AU - Takacs, Peter

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Introduction and hypothesis: The aim of this study was to quantify the effects of estrogen on vaginal smooth muscle cell (SMC) tropoelastin and transforming growth factor (TGF)-β1 production. Methods: Primary SMC were incubated with estradiol, and cell proliferation was assessed by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay at 48 h. Supernatants were collected and tropoelastin and TGF-β1 levels measured. Results: SMC proliferation was significantly increased by estradiol [relative cell number, mean ± standard error (SE), estradiol 0.1 μM 116 ± 19 % of control (P = NS), 1 μM 127 ± 13 % of control (P < 0.05), 10 μM 153 ± 26 % of control, (P < 0.05)]. Tropoelastin production was significantly decreased by estrogen [mean ± SE, estradiol 0.1 μM 78 ± 2 % of control (P < 0.05), 1 μM 76 ± 4 % of control (P < 0.05), 10 μM 67 ± 3 % of control, (P < 0.05)]. In addition, TGF-β1 production was significantly decreased [mean ± SE, estradiol 0.1 μM 96 ± 4 % of control (P = NS), 1 μM 84 ± 6 % of control (P < 0.05), 10 μM 70 ± 6 % of control, (P < 0.05)]. Conclusion: Estrogen increases vaginal SMC proliferation and inhibits tropoelastin and TGF-β1 production.

AB - Introduction and hypothesis: The aim of this study was to quantify the effects of estrogen on vaginal smooth muscle cell (SMC) tropoelastin and transforming growth factor (TGF)-β1 production. Methods: Primary SMC were incubated with estradiol, and cell proliferation was assessed by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay at 48 h. Supernatants were collected and tropoelastin and TGF-β1 levels measured. Results: SMC proliferation was significantly increased by estradiol [relative cell number, mean ± standard error (SE), estradiol 0.1 μM 116 ± 19 % of control (P = NS), 1 μM 127 ± 13 % of control (P < 0.05), 10 μM 153 ± 26 % of control, (P < 0.05)]. Tropoelastin production was significantly decreased by estrogen [mean ± SE, estradiol 0.1 μM 78 ± 2 % of control (P < 0.05), 1 μM 76 ± 4 % of control (P < 0.05), 10 μM 67 ± 3 % of control, (P < 0.05)]. In addition, TGF-β1 production was significantly decreased [mean ± SE, estradiol 0.1 μM 96 ± 4 % of control (P = NS), 1 μM 84 ± 6 % of control (P < 0.05), 10 μM 70 ± 6 % of control, (P < 0.05)]. Conclusion: Estrogen increases vaginal SMC proliferation and inhibits tropoelastin and TGF-β1 production.

KW - Elastin

KW - Estrogen

KW - Transforming growth factor β1

KW - Vagina

UR - http://www.scopus.com/inward/record.url?scp=84877603554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877603554&partnerID=8YFLogxK

U2 - 10.1007/s00192-012-1828-6

DO - 10.1007/s00192-012-1828-6

M3 - Article

VL - 23

SP - 1791

EP - 1795

JO - International Urogynecology Journal and Pelvic Floor Dysfunction

JF - International Urogynecology Journal and Pelvic Floor Dysfunction

SN - 0937-3462

IS - 12

ER -